Watch Ticker

RenovoRx, Inc. Common Stock

Go to RenovoRx, Inc. Common Stock Website

$1.23

0.01 (0.41%)

Live

Previous Close

$1.22

Day Range

$1.2 - $1.234

Previous Day Range

$1.2 - $1.24

Market Cap

$44.3 million USD

Day Vol.

42819

Previous Day Vol.

42586

Currency

USD

Primary Exchange

Nasdaq

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Tra...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

RenovoRx, Inc. - University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial

Ongoing Study is Investigating RenovoGem™ to treat Locally Advanced Pancreatic Cancer Ongoing Study is Investigating RenovoGem™ to treat Locally Advanced Pancreatic Cancer

Related tickers: RNXT.

Read Full Article

RenovoRx, Inc. - RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships

New role highlights RenovoRx’s commitment to explore and execute on clinical and commercial business development opportunities with its therapeutic technology New role highlights RenovoRx’s commitment to explore and execute on clinical and commercial business development opportunities with its therapeutic technology

Related tickers: RNXT.

Read Full Article

Trending Tickers

Please sign in to view